Table 4 Observed, expected and relative survival rates of pancreatic signet ring cell carcinoma (PSRCC) patients from 2000 to 2018
Years | Observed survival (SE) | Expected survival | Relative survival (SE) |
|---|---|---|---|
1 | 20.1% (1.7%) | 97.50% | 20.5% (1.7%) |
2 | 8.30% (1.2%) | 94.90% | 8.70% (1.2%) |
3 | 5.30% (1.0%) | 92.40% | 5.60% (1.0%) |
4 | 3.80% (0.8%) | 89.50% | 4.10% (0.9%) |
5 | 3.40% (0.8%) | 86.60% | 3.70% (0.9%) |